BUGLIONE DI MONALE E BASTIA, Michela
 Distribuzione geografica
Continente #
NA - Nord America 9.314
EU - Europa 3.815
AS - Asia 2.369
AF - Africa 17
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 11
Totale 15.557
Nazione #
US - Stati Uniti d'America 9.285
CN - Cina 1.089
UA - Ucraina 979
DE - Germania 636
SG - Singapore 569
PL - Polonia 563
IT - Italia 556
HK - Hong Kong 335
FI - Finlandia 291
TR - Turchia 196
RU - Federazione Russa 183
IE - Irlanda 182
GB - Regno Unito 168
FR - Francia 130
VN - Vietnam 52
IN - India 45
ID - Indonesia 34
CZ - Repubblica Ceca 30
SE - Svezia 29
CA - Canada 24
BE - Belgio 17
EU - Europa 14
NL - Olanda 12
AU - Australia 10
BR - Brasile 8
IR - Iran 8
JP - Giappone 8
GR - Grecia 6
AR - Argentina 5
BY - Bielorussia 5
MA - Marocco 5
TW - Taiwan 5
AT - Austria 4
AL - Albania 3
BD - Bangladesh 3
EG - Egitto 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
MU - Mauritius 3
PK - Pakistan 3
TN - Tunisia 3
AM - Armenia 2
CH - Svizzera 2
DK - Danimarca 2
EC - Ecuador 2
ES - Italia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
KR - Corea 2
MY - Malesia 2
NO - Norvegia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SL - Sierra Leone 2
SV - El Salvador 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LT - Lituania 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 15.557
Città #
Fairfield 1.304
Woodbridge 1.085
Ashburn 798
Jacksonville 724
Houston 678
Seattle 562
Warsaw 560
Cambridge 538
Chandler 535
Ann Arbor 495
Singapore 491
Wilmington 470
Princeton 337
Hong Kong 332
New York 247
Nanjing 211
Beijing 187
Helsinki 183
Dublin 182
Dearborn 178
Istanbul 169
Brescia 97
Nanchang 89
Shanghai 81
Moscow 80
San Diego 71
Des Moines 70
Milan 64
Changsha 54
Dong Ket 52
Shenyang 50
Hebei 49
Jinan 47
Washington 43
Boardman 41
Los Angeles 38
Munich 38
Tianjin 38
Jiaxing 36
Kunming 34
Jakarta 28
Brno 26
London 26
Hangzhou 25
San Francisco 23
Lancaster 22
Ningbo 21
Zhengzhou 19
Kocaeli 18
Brussels 17
Toronto 17
Ceto 16
Taizhou 16
Haikou 15
Nürnberg 15
Rome 15
Verona 15
Norwalk 13
Guangzhou 12
Lanzhou 12
Redwood City 12
Romola 12
Orange 10
Pune 10
Changchun 9
Dresden 8
Iseo 8
Kilburn 8
San Mateo 8
Vignate 8
Espoo 7
Hefei 7
Athens 6
Phoenix 6
Santa Clara 6
Cazzago San Martino 5
Hounslow 5
Leawood 5
Monza 5
New Bedfont 5
North York 5
Tokyo 5
Amsterdam 4
Ardabil 4
Augusta 4
Buenos Aires 4
Chiswick 4
Chongqing 4
Cremona 4
Delhi 4
Falkenstein 4
Falls Church 4
Frankfurt am Main 4
Fuzhou 4
Gunzenhausen 4
Melbourne 4
Sydney 4
Taiyuan 4
Treviglio 4
Vienna 4
Totale 11.941
Nome #
Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma 216
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 212
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 206
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 199
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 187
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 165
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 158
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 152
Pros-IT CNR: an Italian prostate cancer monitoring project 151
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 149
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 148
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 148
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 147
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 145
Radiotherapy in patients with HIV: current issues and review of the literature 145
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 144
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 141
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 139
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 136
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 133
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 133
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 133
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 132
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 131
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 127
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 126
Role of external beam radiotherapy in the treatment of relapsing meningioma 126
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 126
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 126
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 125
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 123
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 123
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 122
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 119
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 118
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 118
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 117
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 116
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 116
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 115
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 115
Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection? 115
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 114
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 114
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 114
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 113
From Molecular to Clinical Radiation Biology of Glioblastoma 112
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 112
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 112
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 112
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 111
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 111
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 111
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 110
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 110
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 110
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 109
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 108
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 108
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 108
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 108
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 107
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 107
Information Retrieval in Medicine: an Extensive Experimental Study 102
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 102
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 101
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 98
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 97
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 96
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 96
Cetuximab and Radiation Therapy in Head and Neck Cancer 96
Nasopharyngeal carcinoma 95
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 95
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 94
Letter to “Medial lingual lymph node metastasis in carcinoma of the tongue” 94
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 93
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 93
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 92
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 92
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 92
Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. 91
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 91
Post-ABVD/pre-radiotherapy 18F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: A retrospective analysis on 165 patients 91
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 90
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 90
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 89
Practical prognostic score for predicting the extent of resection and neurological outcome of gliomas in the sensorimotor area 89
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 88
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 88
Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis. 87
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 87
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 86
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 85
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). 84
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) 84
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 83
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. 82
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 82
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 81
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 80
Totale 11.600
Categoria #
all - tutte 82.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.542 0 0 0 0 0 510 417 442 305 499 139 230
2020/20212.932 79 282 136 327 151 357 113 316 320 394 262 195
2021/20221.355 110 197 38 58 16 75 54 113 75 161 86 372
2022/20231.362 188 88 47 103 126 339 6 138 214 17 53 43
2023/20241.813 87 32 192 94 97 413 64 80 350 53 79 272
2024/20251.201 31 41 29 491 333 276 0 0 0 0 0 0
Totale 15.962